Nectar Lifesciences has an EPS of $-1.08. In 2022, the company made an earnings per share (EPS) of $1.12. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$1.08 | -196.43% |
2022 | $1.12 | -134.25% |
2021 | -$3.27 | -330.28% |
2020 | $1.42 | - |